Enhanced Group Inc.
ENHA
Positions held
Your positionsENHA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $526.22M | Enterprise value | $151.93M | Trailing P/E | — | Forward P/E | -19.95 |
| PEG | — | Price / book | 55.42 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | -2.3% | Operating margin | -2.9% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | 0.89 | Free cash flow | — | Analyst recommendation | none | Mean target | $4.00 |
| 52w high | $10.17 | 52w low | $1.32 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|
| Revenue | $17.7M | $0.0M | $0.0M | $0.0M |
| Op margin | -349.8% | -600410.5% | — | — |
| Net income | -$61.9M | -$16.4M | -$3.0M | -$3.3M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$61.9M | -$16.5M | -$3.1M | -$3.3M |
- Revenue +642375% vs prior quarter ($18M vs $0.0M).
- Operating margin expanded to -349.8%.
Yearly (6y)
| 2025 | 2024 | |
|---|---|---|
| Revenue | $0.0M | $0.0M |
| Op margin | — | — |
| Net income | -$26.7M | -$4.7M |
| Gross margin | — | — |
| Gross profit | — | — |
| Operating income | -$26.9M | -$4.5M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-28 · Enhanced Group Announces Proposed 1-for-10 Reverse Stock Split
2026-09-15 · Enhanced to Participate in the CG WELL Summit Hosted by Canaccord Genuity
2026-08-18 · Enhanced Announces Enhanced OS the AI Powered Operating System for Delivering Human Potential
2026-08-17 · Enhanced Games Reinforce Audience & Sponsorship, Focus Shifts to Live Enhanced Conversion – Quarterly Update Report
2026-08-14 · Enhanced Group Q2 Earnings Call Highlights
2026-08-13 · Enhanced Group, Inc. Reports Second Quarter 2026 Results
2026-08-06 · Enhanced Group to Report Second Quarter 2026 Financial Results
2026-07-30 · Enhanced Announces Significant Expansion of Supplement Line to 33 International Markets
2026-07-27 · Enhanced Applauds FDA Advisory Committee's Landmark Vote to Expand Legal Compounding Pathway for Peptides
Price (daily)
Full chart · RSI · MACD · patterns